CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Operating Officer acquired 12,000 shares (grant or award)
- 4 Grant or award CFO and CBO acquired 12,000 shares (grant or award)
- 4 Grant or award President and Chief Executive acquired 12,000 shares (grant or award)
- 4 Open-market buy Chief Operating Officer bought 20,000 shares at $8.16 ($163,288)
- 4 Open-market buy President and Chief Executive bought 20,500 shares at $7.41 ($151,835)
- 4 Open-market buy CFO and CBO bought 6,000 shares
- 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CFO and CBO acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 18 shares at $19.00 ($342)
- 4/A Insider Changes in Ownership
- 4 Open-market buy Director bought 9,798 shares at $19.00 ($186,162)
Page 7 of 12 · 224 filings